Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joanna Horobin currently holds 33,755 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joanna Horobin has been a net seller of KYMR stock. They have purchased $7.5K and sold $416.3K worth of shares.
Joanna Horobin's most recent insider trade was on Aug 19, 2025, when they sold 5,000 shares at $27.17 per share.
Joanna Horobin serves as Executive at Kymera Therapeutics, Inc. (KYMR). They have executed 15 insider transactions totaling $423.8K over their tenure at the company.
Joanna Horobin holds the position of Executive at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Joanna Horobin has shown a selling trading pattern, with $7.5K in total purchases and $416.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joanna Horobin was on Jun 7, 2024, when they sold $209.0K worth of KYMR shares. This transaction involved 6,313 shares at $33.11 per share.
Joanna Horobin currently owns 33,755 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joanna Horobin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joanna Horobin has 15 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Joanna Horobin and 40,000+ other insiders.